
Mesa Laboratories, Inc.: updates and filings
Price
$134.60
November 17, 2026Market cap $744M
What Ploutos Investor adds for Mesa Laboratories
Part of Ploutos Investor, €9.99 a month
- The full history: 16 fiscal years, from FY2011
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Notes on these figures
- The interest the company pays is far more than the debt we can read would cost, so part of its borrowing is missing from the figures. We leave out the debt, net cash, enterprise value and the multiples built on them.
What comes next, and what happened
Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.
Next results
last Nov 9, 2026next Feb 5, 2027
An estimate from when it has reported before, which has been regular. The company announces the date itself.
November 2026
September 2026
August 2026
June 2026
March 2026
Its SEC filings
What it has filed lately, newest first, linked to the document itself.
- Nov 9, 2026Results of operationsForm8-K
- Nov 9, 2026Quarterly reportfor the period to Sep 30, 2026Form10-Q
- Oct 27, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Oct 13, 2026Restructuring costs, Regulation FD disclosureForm8-K
- Oct 9, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Sep 8, 2026Shareholder voteForm8-K
- Aug 10, 2026Quarterly reportfor the period to Jun 30, 2026Form10-Q
- Aug 10, 2026Results of operationsForm8-K
- Jul 30, 2026Material eventForm8-K
- Jul 22, 2026Annual meeting proxy statementFormDEF 14A
- Jul 7, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Jun 15, 2026Officer or director changeForm8-K
- Jun 3, 2026Shares registered for employeesFormS-8
- Jun 3, 2026Annual reportfor the period to Mar 31, 2026Form10-K
- May 27, 2026Results of operationsForm8-K
- Apr 15, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Mar 27, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Mar 23, 2026Officer or director changeForm8-K
- Mar 13, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Mar 9, 2026Officer or director change, Regulation FD disclosureForm8-K
- Feb 3, 2026Quarterly reportfor the period to Dec 31, 2025Form10-Q
- Feb 3, 2026Results of operationsForm8-K
- Nov 6, 2025Quarterly reportfor the period to Sep 30, 2025Form10-Q
- Nov 6, 2025Results of operationsForm8-K
- Oct 31, 2025Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Nov 9, 2026 | 8-K | Results of operations | Document |
| Nov 9, 2026 | 10-Q | Quarterly reportfor the period to Sep 30, 2026 | Document |
| Oct 27, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Oct 13, 2026 | 8-K | Restructuring costs, Regulation FD disclosure | Document |
| Oct 9, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Sep 8, 2026 | 8-K | Shareholder vote | Document |
| Aug 10, 2026 | 10-Q | Quarterly reportfor the period to Jun 30, 2026 | Document |
| Aug 10, 2026 | 8-K | Results of operations | Document |
| Jul 30, 2026 | 8-K | Material event | Document |
| Jul 22, 2026 | DEF 14A | Annual meeting proxy statement | Document |
| Jul 7, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Jun 15, 2026 | 8-K | Officer or director change | Document |
| Jun 3, 2026 | S-8 | Shares registered for employees | Document |
| Jun 3, 2026 | 10-K | Annual reportfor the period to Mar 31, 2026 | Document |
| May 27, 2026 | 8-K | Results of operations | Document |
| Apr 15, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Mar 27, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Mar 23, 2026 | 8-K | Officer or director change | Document |
| Mar 13, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Mar 9, 2026 | 8-K | Officer or director change, Regulation FD disclosure | Document |
| Feb 3, 2026 | 10-Q | Quarterly reportfor the period to Dec 31, 2025 | Document |
| Feb 3, 2026 | 8-K | Results of operations | Document |
| Nov 6, 2025 | 10-Q | Quarterly reportfor the period to Sep 30, 2025 | Document |
| Nov 6, 2025 | 8-K | Results of operations | Document |
| Oct 31, 2025 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Dec 11, 1995.
The full analysis
What do Mesa Laboratories's filings show?
The filings are where every one of Mesa Laboratories's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.